The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Abercrombie, E. D., Keefe, K. A., DiFrischia, D. S., & Zigmond, M. J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09224.x · Cited by 1,106
Selective activation of the mesocortical DA system by stress
THIERRY, A. M., TASSIN, J. P., BLANC, G., & GLOWINSKI, J. (1976) · Nature · doi:10.1038/263242a0 · Cited by 1,033
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Regulation of serotonin-2C receptor G-protein coupling by RNA editing
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H., Sanders-Bush, E., & Emeson, R. B. (1997) · Nature · doi:10.1038/387303a0 · Cited by 1,010 · cited 1×
“5-HT2C receptors undergo RNA editing that generates different isoforms of the receptor (Burns et al., 1997).”
BackgroundPompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881
Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding
Kilpatrick, G. J., Jones, B. J., & Tyers, M. B. (1987) · Nature · doi:10.1038/330746a0 · Cited by 865
Pazos, A., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820
Zahrt, J., Taylor, J. R., Mathew, R. G., & Arnsten, A. F. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08528.1997 · Cited by 796
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Neurotransmitter regulation of dopamine neurons in the ventral tegmental area
Kalivas, P. W. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90008-n · Cited by 708
Pompeiano, M., Palacios, J., & Mengod, G. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00440.1992 · Cited by 698
Molecular Characterization of a Functional cDNA Encoding the Serotonin 1c Receptor
Julius, D., MacDermott, A. B., Axel, R., & Jessell, T. M. (1988) · Science · doi:10.1126/science.3399891 · Cited by 694
Araneda, R., & Andrade, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90128-b · Cited by 625
5-HT3 receptors are membrane ion channels
Derkach, V., Surprenant, A., & North, R. A. (1989) · Nature · doi:10.1038/339706a0 · Cited by 625
Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., & Schwartz, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M., & Jennes, L. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903510304 · Cited by 549
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Parent, A., Descarries, L., & Beaudet, A. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90050-6 · Cited by 524
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
KENNETT, G. A., WOOD, M. D., BRIGHT, F., TRAIL, B., RILEY, G., HOLLAND, V., AVENELL, K. Y., STEAN, T., UPTON, N., BROMIDGE, S., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00038-5 · Cited by 523
Buckmaster, P. S., & Dudek, F. E. (1997) · Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970901)385:3<385::aid-cne4>3.0.co;2-# · Cited by 522
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Riad, M., Garcia, S., Watkins, K. C., Jodoin, N., Doucet, �., Langlois, X., El Mestikawy, S., Hamon, M., & Descarries, L. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000207)417:2<181::aid-cne4>3.0.co;2-a · Cited by 513
Ichikawa, J., Ishii, H., Bonaccorso, S., Fowler, W. L., O'Laughlin, I. A., & Meltzer, H. Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00154.x · Cited by 494
Santana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486
Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., & Schmauss, C. (2002) · Neuron · doi:10.1016/s0896-6273(02)00660-8 · Cited by 377
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS
Clemett, D. A., Punhani, T., S. Duxon, M., Blackburn, T. P., & Fone, K. C. F. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00086-6 · Cited by 373
Hervé, D., Pickel, V. M., Joh, T. H., & Beaudet, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91588-5 · Cited by 372
Nervous system distribution of the serotonin 5-HT3 receptor mRNA.
Tecott, L. H., Maricq, A. V., & Julius, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1430 · Cited by 368
The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals
Boschert, U., Aït. Amara, D., Segu, L., & Hen, R. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90164-3 · Cited by 351
Bruinvels, A. T., Landwehrmeyer, B., Gustafson, E. L., Durkin, M. M., Mengod, G., Branchek, T. A., Hoyer, D., & Palacios, J. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90067-1 · Cited by 349
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
Willins, D. L., Deutch, A. Y., & Roth, B. L. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a · Cited by 345
Martı́n-Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 339
Gobert, A., Rivet, J.-M., Lejeune, F., Newman-Tancredi, A., Adhumeau-Auclair, A., Nicolas, J.-P., Cistarelli, L., Melon, C., & Millan, M. J. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · Cited by 336
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system
Gérard, C., Martres, M.-P., Lefèvre, K., Miquel, M.-C., Vergé, D., Lanfumey, L., Doucet, E., Hamon, M., & El Mestikawy, S. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01224-3 · Cited by 326
De Deurwaerdère, P., Navailles, S., Berg, K. A., Clarke, W. P., & Spampinato, U. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0112-04.2004 · Cited by 306
Vollenweider, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00108-0 · Cited by 305
Cellular localization of the 5-HT receptor in primate brain neurons and glial cells
AZMITIA, E., GANNON, P., KHECK, N., & WHITAKERAZINITIA, P. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)80057-1 · Cited by 305
Weinshank, R. L., Zgombick, J. M., Macchi, M. J., Branchek, T. A., & Hartig, P. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3630 · Cited by 294
Antidepressant-Like Behavioral Effects Mediated by 5-Hydroxytryptamine2C Receptors
Cryan, J. F., & Lucki, I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39013-5 · Cited by 293
Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors
Millan, M. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38982-7 · Cited by 287
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A., Toth, M., Celada, P., & Artigas, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 285
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 283
Millan, M. J., Dekeyne, A., & Gobert, A. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00078-1 · Cited by 283
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
Molineaux, S. M., Jessell, T. M., Axel, R., & Julius, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6793 · Cited by 261
The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat
Bolam, J. P., & Smith, Y. (1990) · Brain Research · doi:10.1016/0006-8993(90)90811-o · Cited by 260
5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line
Yakel, J. L., & Jackson, M. B. (1988) · Neuron · doi:10.1016/0896-6273(88)90111-0 · Cited by 259
Niswender, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00223-2 · Cited by 256
Parsons, L. H., & Justice, J. B. (1993) · Brain Research · doi:10.1016/0006-8993(93)90984-u · Cited by 253
Fletcher, P. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00342-1 · Cited by 251
Di Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00047-7 · Cited by 251
5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons
Johnson, S., Mercuri, N., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-02000.1992 · Cited by 248
Dawson, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00265-2 · Cited by 245
Abramowski, D., Rigo, M., Duc, D., Hoyer, D., & Staufenbiel, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00138-7 · Cited by 243
Kennett, G. A., Wood, M. D., Bright, F., Cilia, J., Piper, D. C., Gager, T., Thomas, D., Baxter, G. S., Forbes, I. T., Ham, P., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15208.x · Cited by 240
Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
Blandina, P., Goldfarb, J., Craddock-Royal, B., & Green, J. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21081-3 · Cited by 240
Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats
Eberle-Wang, K., Mikeladze, Z. A., Uryu, K., & Chesselet, M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970728)384:2<233::aid-cne5>3.0.co;2-2 · Cited by 237
Bruinvels, A. T., Palacios, J. M., & Hoyer, D. (1993) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00166939 · Cited by 234
5-HT6 receptors: a novel target for cognitive enhancement
Mitchell, E. S., & Neumaier, J. F. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.001 · Cited by 233
Functional hyperdopaminergia in dopamine transporter knock-out mice
Gainetdinov, R. R., Jones, S. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00122-5 · Cited by 232
Zhang, W. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00119-6 · Cited by 232
Kilpatrick, G. J., Jones, B. J., & Tyers, M. B. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90700-0 · Cited by 231
Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
Benloucif, S., Keegan, M. J., & Galloway, M. P. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38133-4 · Cited by 229
Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis
Benloucif, S., & Galloway, M. P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90658-d · Cited by 229
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Hamblin, M. W., & Metcalf, M. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12918-0 · Cited by 228
The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity
Bortolozzi, A., Díaz‐Mataix, L., Scorza, M. C., Celada, P., & Artigas, F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03485.x · Cited by 224
Porras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222
Sari, Y., Miquel, M.-C., Brisorgueil, M.-J., Ruiz, G., Doucet, E., Hamon, M., & Vergé, D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00256-5 · Cited by 222
Di Giovanni, G., De Deurwaerdére, P., Di Mascio, M., Di Matteo, V, Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 218
Miner, L. A. H., Backstrom, J. R., Sanders-Bush, E., & Sesack, S. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00580-8 · Cited by 216
Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.
Kalivas, P. W., Duffy, P., & Barrow, J. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20732-7 · Cited by 215
Prisco, S., Pagannone, S., & Esposito, E. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214
Multiple Serotonin Receptors: Clinical and Experimental Aspects
Roth, B. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148985 · Cited by 213
Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways
Geyer, M. A., Puerto, A., Dawsey, W. J., Knapp, S., Bullard, W. P., & Mandell, A. J. (1976) · Brain Research · doi:10.1016/0006-8993(76)91023-4 · Cited by 213
Lovinger, D. M., & White, G. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12934-9 · Cited by 213
Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
Grottick, A. J., Fletcher, P. J., & Higgins, G. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39021-4 · Cited by 211
Duxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., & Fone, K. C. F. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00480-0 · Cited by 210
Overton, P., & Clark, D. (1992) · Synapse · doi:10.1002/syn.890100208 · Cited by 208
Neumaier, J. F., Sexton, T. J., Yracheta, J., Diaz, A. M., & Brownfield, M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00092-2 · Cited by 204
5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics
Weiner, D. M., Burstein, E. S., Nash, N., Croston, G. E., Currier, E. A., Vanover, K. E., Harvey, S. C., Donohue, E., Hansen, H. C., Andersson, C. M., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29327-7 · Cited by 203
Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation
Rollema, H., Lu, Y., Schmidt, A. W., & Zorn, S. H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)81951-6 · Cited by 203
Pehek, E. A., Nocjar, C., Roth, B. L., Byrd, T. A., & Mabrouk, O. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300819 · Cited by 202
Self-citationChen, J., van Praag, H. M., & Gardner, E. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90050-6 · Cited by 200
Morales, M., Battenberg, E., & Bloom, F. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981221)402:3<385::aid-cne7>3.0.co;2-q · Cited by 200
Rollema, H., Lu, Y., Schmidt, A. W., Sprouse, J. S., & Zorn, S. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00850-7 · Cited by 195
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<172::aid-syn7>3.0.co;2-9 · Cited by 195
G�rard, C., Mestikawy, S. E., Lebrand, C., Adrien, J., Ruat, M., Traiffort, É., Hamon, M., & Martres, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199607)23:3<164::aid-syn5>3.0.co;2-6 · Cited by 193
Cocaine inhibits GABA release in the VTA through endogenous 5-HT
Cameron, D., & Williams, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06763.1994 · Cited by 188
Carli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300893 · Cited by 187
Di Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184
Prisco, S., & Esposito, E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16684.x · Cited by 181
Di Giovanni, G., Di Matteo, V., Di Mascio, M., & Esposito, E. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1<53::aid-syn7>3.0.co;2-2 · Cited by 179
Doherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 177
Zangen, A., Nakash, R., Overstreet, D., & Yadid, G. (2001) · Psychopharmacology · doi:10.1007/s002130100746 · Cited by 177
Blockage of 5HT2Cserotonin receptors by fluoxetine (Prozac)
Ni, Y. G., & Miledi, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2036 · Cited by 177
Serotonin1BReceptor Stimulation Enhances Cocaine Reinforcement
Parsons, L. H., Weiss, F., & Koob, G. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10078.1998 · Cited by 174
Modulation of dopamine release by striatal 5‐HT2C receptors
Alex, K. D., Yavanian, G. J., McFarlane, H. G., Pluto, C. P., & Pehek, E. A. (2005) · Synapse · doi:10.1002/syn.20109 · Cited by 172
Self-citationLocalization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 171
Self-citationGobert, A., & Millan, M. J. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00188-9 · Cited by 171
Kelland, M. D., Freeman, A. S., & Chiodo, L. A. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13049-8 · Cited by 171
Adham, N., Romanienko, P., Hartig, P., Weinshank, R. L., & Branchek, T. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08798-x · Cited by 171
Lucas, G., & Spampinato, U. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740693.x · Cited by 170
Laporte, A. M., Koscielniak, T., Ponchant, M., Vergé, D., Hamon, M., & Gozlan, H. (1992) · Synapse · doi:10.1002/syn.890100402 · Cited by 168
Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra
Nedergaard, S., Bolam, J. P., & Greenfield, S. A. (1988) · Nature · doi:10.1038/333174a0 · Cited by 166
Arborelius, L., Chergui, K., Murase, S., Nomikos, G. G., Backlund H��k, B., Chouvet, G., Hacksell, U., & Svensson, T. H. (1993) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00165384 · Cited by 165
De Deurwaerdère, P., & Spampinato, U. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731033.x · Cited by 164
Auclair, A., Drouin, C., Cotecchia, S., Glowinski, J., & Tassin, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03805.x · Cited by 163
5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra
Bouhelal, R., Smounya, L., & Bockaert, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90799-6 · Cited by 163
The 5-HT7 receptor: orphan found
Eglen, R. M., Jasper, J. R., Chang, D. J., & Martin, G. R. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01043-2 · Cited by 162
Distribution of serotonin 5‐HT1C receptor mRNA in adult rat brain
Hoffman, B. J., & Mezey, E. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81390-0 · Cited by 160
Activation of a 5-HT3 receptor releases dopamine from rat striatal slice
Blandina, P., Goldfarb, J., & Green, J. P. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90528-6 · Cited by 159
Ji, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 158
Rocha, B. A., Goulding, E. H., O'Dell, L. E., Mead, A. N., Coufal, N. G., Parsons, L. H., & Tecott, L. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-10039.2002 · Cited by 158
Jiang, L. H., Ashby, C. R., Kasser, R. J., & Wang, R. Y. (1990) · Brain Research · doi:10.1016/0006-8993(90)91103-n · Cited by 156
Marek, G. J., & Aghajanian, G. K. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20792-3 · Cited by 156
5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats
Impérato, A., & Angelucci, L. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90533-8 · Cited by 155
Fischette, C. T., Nock, B. L., & Renner, K. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)91296-0 · Cited by 155
Sanders‐Bush, E., Burris, K. D., & Knoth, K. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22189-9 · Cited by 154
Pasqualetti, M., Ori, M., Castagna, M., Marazziti, D., Cassano, G. B., & Nardi, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00011-1 · Cited by 154
Deurwaerdère, P. D., Stinus, L., & Spampinato, U. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06528.1998 · Cited by 152
Lacroix, L. P., Dawson, L. A., Hagan, J. J., & Heidbreder, C. A. (2003) · Synapse · doi:10.1002/syn.10288 · Cited by 150
Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens
Campbell, A. D., & McBride, W. J. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00050-7 · Cited by 150
Vilaró, M. T., Cortés, R., & Mengod, G. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20447 · Cited by 148
Serotonergic involvement in haloperidol-induced catalepsy.
Neal‐Beliveau, B. S., Joyce, J. N., & Lucki, I. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38100-0 · Cited by 148
Morales, M., Battenberg, E., de Lecea, L., & Bloom, F. E. (1996) · Brain Research · doi:10.1016/0006-8993(96)00557-4 · Cited by 145
Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine
Wozniak, K. M., Pert, A., & Linnoila, M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90015-x · Cited by 144
Bonhomme, N., Deurwaerdère, P. D., Moal, M. L., & Spampinato, U. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00145-i · Cited by 143
Yamamoto, B. K., Nash, J. F., & Gudelsky, G. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09555-2 · Cited by 142
Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro
Pessia, M., Jiang, Z., North, R. A., & Johnson, S. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90495-2 · Cited by 138
Liégeois, J.-F., Ichikawa, J., & Meltzer, H. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02620-3 · Cited by 137
Smolders, I. J., Klippel, N. D., Sarre, S., Ebinger, G., & Michotte, Y. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00369-v · Cited by 136
Schmidt, C. J., Sullivan, C. K., & Fedayal, G. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041382.x · Cited by 132
Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
Iyer, R. N., & Bradberry, C. W. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12836-x · Cited by 131
Pehek, E. A., McFarlane, H. G., Maguschak, K. A., Price, B., & Pluto, C. P. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03004-3 · Cited by 131
Self-citationBarnes, J. M., Barnes, N. M., Champaneria, S., Costall, B., & Naylor, R. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90110-d · Cited by 131
Filip, M., Bubar, M. J., & Cunningham, K. A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068841 · Cited by 130
Lesion Study of the Distribution of Serotonin 5‐HT 4 Receptors in Rat Basal Ganglia and Hippocampus
Compan, V., Daszuta, A., Salin, P., Sebben, M., Bockaert, J., & Dumuis, A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01553.x · Cited by 130
Fletcher, P. J., Chintoh, A. F., Sinyard, J., & Higgins, G. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300319 · Cited by 129
Assié, M., Ravailhe, V., Faucillon, V., & Newman‐Tancredi, A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087163 · Cited by 127
Palfreyman, M. G., Schmidt, C. J., Sorensen, S. M., Dudley, M. W., Kehne, J. H., Moser, P. C., Gittos, M. W., & Carr, A. A. (1993) · Psychopharmacology · doi:10.1007/bf02245008 · Cited by 126
Giovanni, G. D., Matteo, V. D., Grutta, V. L., & Esposito, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00561-3 · Cited by 125
Localization of 5-HT3 receptors in the rat brain using [3H]LY278584
Gehlert, D. R., Gackenheimer, S. L., Wong, D. T., & Robertson, D. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90242-n · Cited by 121
Schmidt, C. J., & Fadayel, G. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13106-6 · Cited by 120
Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release
Campbell, A. D., Kohl, R. R., & McBride, W. J. (1996) · Alcohol · doi:10.1016/s0741-8329(96)00069-9 · Cited by 120
Ichikawa, J., & Meltzer, H. Y. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02346-x · Cited by 120
Westerink, B. H. C., Kawahara, Y., Boer, P. D., Geels, C., Vries, J. B. D., Wikström, H., Kalkeren, A. A. V., Vliet, B. J. V., Kruse, C. G., & Long, S. K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00935-3 · Cited by 120
Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat
Yoshimoto, K., & McBride, W. J. (1992) · Neurochemical Research · doi:10.1007/bf00969884 · Cited by 118
Hamada, S., Senzaki, K., Hamaguchi‐Hamada, K., Tabuchi, K., Yamamoto, H., Yamamoto, T., Yoshikawa, S., Okano, H., & Okado, N. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00322-7 · Cited by 116
Elevated Expression of 5-HT1BReceptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine
Neumaier, J. F., Vincow, E. S., Arvanitogiannis, A., Wise, R. A., & Carlezon, W. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10856.2002 · Cited by 115
Nelson, D. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482606 · Cited by 113
Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors
Berg, K. A., Harvey, J. A., Spampinato, U., & Clarke, W. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.008 · Cited by 111
DeFelipe, J., Arellano, J. I., Gómez, A., Azmitia, E. C., & Muñoz, A. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1132 · Cited by 109
Filip, M., & Cunningham, K. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045716 · Cited by 109
Matteo, V. D., Giovanni, G. D., Mascio, M. D., & Esposito, E. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00014-8 · Cited by 107
Dremencov, E., Newman, M. E., Kinor, N., Blatman‐Jan, G., Schindler, C. J., Overstreet, D. H., & Yadid, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.013 · Cited by 107
Wadenberg, M.-L., & Ahlenius, S. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244451 · Cited by 106
Lucas, G., Bonhomme, N., Deurwaerdère, P. D., Moal, M. L., & Spampinato, U. (1997) · Psychopharmacology · doi:10.1007/s002130050265 · Cited by 105
O’Dell, L. E., & Parsons, L. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069278 · Cited by 105
Barr, A. M., Lehmann-Masten, V., Paulus, M., Gainetdinov, R. R., Caron, M. G., & Geyer, M. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300343 · Cited by 103
Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
Callahan, P. M., & Cunningham, K. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10686-1 · Cited by 103
Seutin, V., Verbanck, P., Massotte, L., & Dresse, A. (1990) · Brain Research · doi:10.1016/0006-8993(90)90448-k · Cited by 102
(R)‐8‐OH‐DPAT preferentially increases dopamine release in rat medial prefrontal cortex
Arborelius, L., Nomikos, G. G., Hacksell, U., & Svensson, T. H. (1993) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1993.tb09584.x · Cited by 102
Navailles, S., Deurwaerdère, P. D., Porras, G., & Spampinato, U. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300329 · Cited by 101
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning
Carboni, E., Acquas, E., Leone, P., Perezzani, L., & Chiara, G. D. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90710-8 · Cited by 98
Pozzi, L., Acconcia, S., Ceglia, I., Invernizzi, R. W., & SAMANIN, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00947.x · Cited by 96
Rick, C., Stanford, I. M., & Lacey, M. G. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00283-o · Cited by 96
Frantz, K. J., Hansson, K. J., Stouffer, D. G., & Parsons, L. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00165-4 · Cited by 94
Rondé, P., & Nichols, R. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031094.x · Cited by 94
Yan, Q., & Yan, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00913-x · Cited by 94
Sorensen, S. M., Humphreys, T. M., & Palfreyman, M. G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90402-0 · Cited by 92
Localization of serotonin-4 receptors in the striatonigral pathway in rat brain
Patel, S., Roberts, J. C., Moorman, J. M., & Reavill, C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00314-9 · Cited by 92
Parsons, L. H., Koob, G. F., & Weiss, F. (1999) · Synapse · Cited by 88
Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning
Higgins, G. A., Joharchi, N., Nguyen, P., & Sellers, E. M. (1992) · Psychopharmacology · doi:10.1007/bf02245411 · Cited by 87
Waeber, C., & Palacios, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90082-1 · Cited by 86
Autoradiographic distribution of [ 3 H]-(S)-zacopride-labelled 5-HT 3 receptors in human brain
Parker, R. M. C., Barnes, J. M., Ge, J., Barber, P. C., & Barnes, N. M. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00211-0 · Cited by 86
Pei, Q., Zetterström, T., Leslie, R. A., & Smith, A. D. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90410-j · Cited by 84
Chen, J., Paredes, W. M., van Praag, H. M., Lowinson, J. H., & Gardner, E. L. (1992) · Synapse · doi:10.1002/syn.890100308 · Cited by 84
Jacocks, H. M., & Cox, B. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10759-3 · Cited by 84
Fox, S. H., Moser, B., & Brotchie, J. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6792 · Cited by 82
Sharma, A., Punhani, T., & Fone, K. C. F. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<45::aid-syn5>3.0.co;2-d · Cited by 81
Bonaccorso, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00311-1 · Cited by 80
DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum
Ichikawa, J., & Meltzer, H. Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00865-n · Cited by 80
Hoyer, D., & Schoeffter, P. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90645-0 · Cited by 79
Serotonin–GABA interactions modulate MDMA‐induced mesolimbic dopamine release
Bankson, M. G., & Yamamoto, B. K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02763.x · Cited by 79
Matteo, V. D., Pierucci, M., & Esposito, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02337.x · Cited by 78
Boess, F., Riemer, C., Bös, M., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.577 · Cited by 77
Hutson, P. H., Barton, C. L., Jay, M. T., Blurton, P., Burkamp, F., Clarkson, R., & Bristow, L. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00089-7 · Cited by 76
Carey, R. J., DePalma, G., Damianopoulos, E. N., M�ller, C., & Huston, J. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1917-4 · Cited by 74
Ability of 5‐HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo
Steward, L. J., Ge, J., Stowe, R. L., Brown, D. C., Bruton, R. K., Stokes, P. R. A., & Barnes, N. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15154.x · Cited by 74
Willins, D. L., & Meltzer, H. Y. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01267-5 · Cited by 74
Serotonin1A Receptors at the Axon Initial Segment of Prefrontal Pyramidal Neurons in Schizophrenia
Cruz, D. A., Eggan, S. M., Azmitia, E. C., & Lewis, D. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.739 · Cited by 72
Cited by
Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 517
Serotonin and dopamine: unifying affective, activational, and decision functions.
Cools, R., Nakamura, K., & Daw, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.121 · Cited by 464
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456
Serotonin in Affective Control
Dayan, P., & Huys, Q. J. M. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135607 · Cited by 381
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-019-0090-z · Cited by 359
Metadata
- Authors
- Alex, K. D., & Pehek, E. A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 113
- Issue
- 2
- Pages
- 296-320
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2016437478
- Cited by
- 658
- References
- 262
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.